Tackling Grand Challenges with Competition Law: Lessons from the Pandemic

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Standard

Tackling Grand Challenges with Competition Law: Lessons from the Pandemic. / Lianos, Ioannis; Minssen, Timo; Kollmar, Christy Lynne.

EU Competition Law and Pharmaceuticals . ed. / Wolf Sauter; Marcel Canoy; Jotte Mulder. Edward Elgar Publishing, 2021.

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Harvard

Lianos, I, Minssen, T & Kollmar, CL 2021, Tackling Grand Challenges with Competition Law: Lessons from the Pandemic. in W Sauter, M Canoy & J Mulder (eds), EU Competition Law and Pharmaceuticals . Edward Elgar Publishing. https://doi.org/10.2139/ssrn.3985344

APA

Lianos, I., Minssen, T., & Kollmar, C. L. (2021). Tackling Grand Challenges with Competition Law: Lessons from the Pandemic. In W. Sauter, M. Canoy, & J. Mulder (Eds.), EU Competition Law and Pharmaceuticals Edward Elgar Publishing. https://doi.org/10.2139/ssrn.3985344

Vancouver

Lianos I, Minssen T, Kollmar CL. Tackling Grand Challenges with Competition Law: Lessons from the Pandemic. In Sauter W, Canoy M, Mulder J, editors, EU Competition Law and Pharmaceuticals . Edward Elgar Publishing. 2021 https://doi.org/10.2139/ssrn.3985344

Author

Lianos, Ioannis ; Minssen, Timo ; Kollmar, Christy Lynne. / Tackling Grand Challenges with Competition Law: Lessons from the Pandemic. EU Competition Law and Pharmaceuticals . editor / Wolf Sauter ; Marcel Canoy ; Jotte Mulder. Edward Elgar Publishing, 2021.

Bibtex

@inbook{b7f40749637c492fb115f697ac7cd040,
title = "Tackling Grand Challenges with Competition Law: Lessons from the Pandemic",
abstract = "All across the globe antitrust authorities responded quickly, determined to tackle the worst impacts of the COVID-19 outbreak. While regulators and courts can apply competition and antitrust rules both as enforcing “swords” to achieve public health goals and “enabling” shields to promote specific collaborations, it appears that the “enabling collaborations” function has been particularly important to rapidly facilitate much needed pandemic responses. This chapter describes these developments from a past, present and future perspective. Specifically, it analyses (1) the interaction between competition law and public health, (2) the immediate response of antitrust authorities during the crisis, and (3) new approaches and solutions models. Special emphasis will be placed on the question of whether current pandemic responses could provide competition authorities a future blueprint and toolkit for action and a new role in the public ecosystem to implement needed sustainable development objectives.",
keywords = "Faculty of Law, competition law, sustainable pharma, grand challenges, public health, coopetition, collaboration, regulatory sandboxes",
author = "Ioannis Lianos and Timo Minssen and Kollmar, {Christy Lynne}",
year = "2021",
doi = "10.2139/ssrn.3985344",
language = "English",
editor = "Wolf Sauter and Marcel Canoy and Jotte Mulder",
booktitle = "EU Competition Law and Pharmaceuticals",
publisher = "Edward Elgar Publishing",
address = "United Kingdom",

}

RIS

TY - CHAP

T1 - Tackling Grand Challenges with Competition Law: Lessons from the Pandemic

AU - Lianos, Ioannis

AU - Minssen, Timo

AU - Kollmar, Christy Lynne

PY - 2021

Y1 - 2021

N2 - All across the globe antitrust authorities responded quickly, determined to tackle the worst impacts of the COVID-19 outbreak. While regulators and courts can apply competition and antitrust rules both as enforcing “swords” to achieve public health goals and “enabling” shields to promote specific collaborations, it appears that the “enabling collaborations” function has been particularly important to rapidly facilitate much needed pandemic responses. This chapter describes these developments from a past, present and future perspective. Specifically, it analyses (1) the interaction between competition law and public health, (2) the immediate response of antitrust authorities during the crisis, and (3) new approaches and solutions models. Special emphasis will be placed on the question of whether current pandemic responses could provide competition authorities a future blueprint and toolkit for action and a new role in the public ecosystem to implement needed sustainable development objectives.

AB - All across the globe antitrust authorities responded quickly, determined to tackle the worst impacts of the COVID-19 outbreak. While regulators and courts can apply competition and antitrust rules both as enforcing “swords” to achieve public health goals and “enabling” shields to promote specific collaborations, it appears that the “enabling collaborations” function has been particularly important to rapidly facilitate much needed pandemic responses. This chapter describes these developments from a past, present and future perspective. Specifically, it analyses (1) the interaction between competition law and public health, (2) the immediate response of antitrust authorities during the crisis, and (3) new approaches and solutions models. Special emphasis will be placed on the question of whether current pandemic responses could provide competition authorities a future blueprint and toolkit for action and a new role in the public ecosystem to implement needed sustainable development objectives.

KW - Faculty of Law

KW - competition law

KW - sustainable pharma

KW - grand challenges

KW - public health

KW - coopetition

KW - collaboration

KW - regulatory sandboxes

UR - https://ssrn.com/abstract=3985344

U2 - 10.2139/ssrn.3985344

DO - 10.2139/ssrn.3985344

M3 - Book chapter

BT - EU Competition Law and Pharmaceuticals

A2 - Sauter, Wolf

A2 - Canoy, Marcel

A2 - Mulder, Jotte

PB - Edward Elgar Publishing

ER -

ID: 284491361